Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
An open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel (nab-PAC) with or without the anti-death receptor 5 monoclonal antibody tigatuzumab in patients with metastatic triple negative breast cancer
Academic Article
Overview
Additional Document Info
Overview
Authors
Yufeng Li Ph.D.
Published In
Journal of Clinical Oncology
Journal
Additional Document Info
Author List
Vaklavas C; Abramson VG; Lin NU; Lin MC; Rugo HS; Nanda R; Storniolo AM; Traina TA; Li Y; Patil S
Volume
31
Issue
15